Hj. Wester et al., Preclinical evaluation of 4-[F-18]fluoroprolines: Diastereomeric effect onmetabolism and uptake in mice, NUCL MED BI, 26(3), 1999, pp. 259-265
The aim of this study was to evaluate the diastereomeric effect on uptake a
nd metabolic behavior of (2S,4R)-4-[F-18]fluoro-L-proline (trans-[F-18]FPro
) and (2S,4S)-4-[F-18]fluoro-L-proline (cis-[F-18]FPro) in view of their po
tential suitability as tracers for abnormal collagen synthesis. No-carrier-
added 4-[F-18]fluoro-L-prolines were prepared according to the literature i
n about 150 min (50-60% radiochemical yield). Both compounds exhibited high
in vivo stability. The tumor uptake of cis-[F-18]FPro in osteosarcomas of
mice was high and at 240 min postinjection reached 11.8 +/- 2.2 %ID/g compa
red with 7.07 +/- 1.68 %ID/g for trans-[F-18]FPro, In contrat to trans-[F-1
8]FPro, which showed fast and complete renal clearance, the cis isomer was
accumulated in the pancreas, and showed hepatic clearance and renal reuptak
e. Speciation studies on tissue homogenates revealed protein incorporation
only for cis-[F-18]FPro. However, due to the relatively slow protein incorp
oration rate of cis-[F-18]FPro, the tumor uptake of both compounds in colon
carcinomas, mammary carcinomas, and osteosarcomas 1 h postinjection predom
inantly reflect amino acid transport. NUCL MED BIOL 26;3:259-265, 1999. (C)
1999 Elsevier Science Ins. All rights reserved.